TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotechst Lund AB
Closing information (x1000 NOK)
| Closing information | 2023/08 | 2022/08 | 2021/08 |
| Turnover |
637
|
740
|
703 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-100
|
67
|
11 |
| EBITDA |
-100
|
67
|
11 |
| Total assets |
334
|
464
|
443 |
| Current assets |
334
|
464
|
443 |
| Current liabilities |
107
|
155
|
170 |
| Equity capital |
226
|
308
|
273 |
| - share capital |
98
|
92
|
101 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Solvency |
67.7%
|
66.4%
|
61.6% |
| Turnover per employee |
637
|
740
|
703 |
| Profit as a percentage of turnover |
-15.7%
|
9.1%
|
1.6% |
| Return on assets (ROA) |
-29.9%
|
14.4%
|
2.5% |
| Current ratio |
312.1%
|
299.4%
|
260.6% |
| Return on equity (ROE) |
-44.2%
|
21.8%
|
4.0% |
| Change turnover |
-147
|
97
|
-7 |
| Change turnover % |
-19%
|
15%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.